{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 1239"}, "official-title": {"#tail": "\n\t", "#text": "To amend part D of title XVIII of the Social Security Act\n\t\t  to count the negotiated price of drugs provided free or at nominal charge under\n\t\t  compassionate treatment programs towards incurred out-of-pocket\n\t\t  costs."}, "session": {"#tail": "\n\t\t", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20130318", "#text": "March 18, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": [{"#tail": ", and in\n\t\t\t addition to the Committee on ", "@committee-id": "HIF00", "#text": "Committee on Energy and Commerce"}, {"#tail": ", for a period to be subsequently determined by the\n\t\t\t Speaker, in each case for consideration of such provisions as fall within the\n\t\t\t jurisdiction of the committee concerned", "@committee-id": "HWM00", "#text": "Ways and\n\t\t\t Means"}], "sponsor": {"#tail": " (for\n\t\t\t himself and ", "#text": "Mr. Cassidy", "@name-id": "C001075"}, "cosponsor": {"#tail": ") introduced the\n\t\t\t following bill; which was referred to the ", "#text": "Ms. Matsui", "@name-id": "M001163"}}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "HE60B26F9DEFC4F92AD8BED1955E7EB53", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "#text": "Accessing Medicare Therapies Act of\n\t\t\t 2013"}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the\n\t\t\t ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "H2A5FD40EB37744E881F4E1B1F1BBA130"}, {"@section-type": "subsequent-section", "#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "Counting the\n\t\t\t negotiated price of drugs provided free or at nominal charge under\n\t\t\t compassionate treatment programs towards incurred out-of-pocket costs"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 1860D\u20132(b)(4)\n\t\t\t of the Social Security Act", "@value": "Social Security Act/s:1860D\u20132/ss:b/p:4"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "42 U.S.C. 1395w\u2013102(b)(4)", "@value": "usc/42/1395w\u2013102/b/4"}, "@parsable-cite": "usc/42/1395w-102", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In\n\t\t\t general"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", by striking ", "@entity-type": "act", "#text": "subparagraph\n\t\t\t (C)", "@value": "Social Security Act/s:1860D\u20132/ss:b/p:4/sp:C"}, "#text": "in ", "quote": [{"#tail": " and inserting\n\t\t\t ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "act", "#text": "subparagraph (E)", "@value": "Social Security Act/s:1860D\u20132/ss:b/p:4/sp:E"}, "#text": "\n              "}, {"#tail": "; and", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and ", "@entity-type": "act", "#text": "subparagraphs (E)", "@value": "Social Security Act/s:1860D\u20132/ss:b/p:4/sp:E"}, {"#tail": "\n            ", "@entity-type": "act", "#text": "(F)", "@value": "Social Security Act/s:1860D\u20132/ss:b/p:4/sp:F"}], "#text": "\n              "}]}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "HD2950193D1A446F38FE8E796994D00AB", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "by adding at the\n\t\t\t end the following new subparagraph:"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "@id": "H87274D01811E4066A5D232162F2CEF47", "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "subparagraph": {"#tail": "\n            ", "clause": [{"#tail": "\n              ", "subclause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", in the\n\t\t\t\thighest copayment tier (such as a tier 4 for specialty brand-name drugs);", "@entity-type": "act", "#text": "section 1860D\u20132(b)(2)(B)", "@value": "Social Security Act/s:1860D\u20132/ss:b/p:2/sp:B"}, "#text": "the drug is classified, for purposes of\n\t\t\t\tapplying tiered copayments consistent with ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(I)"}, "@id": "H3AB2A13935A841B1994D8312FD675338", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "); and", "@entity-type": "act", "#text": "clause (iii)", "@value": "Social Security Act/s:1860D\u20132/ss:b/p:4/sp:F/cl:iii", "@proposed": "true"}, "#text": "the drug is\n\t\t\t\tfurnished to the individual free or at nominal charge under a compassionate\n\t\t\t\ttreatment program (as defined in "}, "enum": {"#tail": "\n                  ", "#text": "(II)"}, "@id": "H5075AEC42F07453BBCB60308B0CB283D", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the drug, if\n\t\t\t\tfurnished other than through such program, is covered under the formulary of\n\t\t\t\tthe plan or is available through exception or appeal."}, "enum": {"#tail": "\n                  ", "#text": "(III)"}, "@id": "HB8F2BE75556246A8B309280FD3FDD9AB", "#text": "\n                  "}], "enum": {"#tail": "\n                ", "#text": "(i)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " with respect to an\n\t\t\t\tindividual enrolled in a prescription drug plan, incurred costs shall include\n\t\t\t\tthe negotiated price described in ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Social Security Act/s:1860D\u20132/ss:b/p:4/sp:A"}, {"#tail": " of a covered part D drug\n\t\t\t\tif\u2014", "@entity-type": "act", "#text": "clause (ii)", "@value": "Social Security Act/s:1860D\u20132/ss:b/p:4/sp:F/cl:ii", "@proposed": "true"}], "#text": "In applying "}, "#text": "\n                ", "@id": "H518C83F6BC7D4CFB84C1D5C7183DD765"}, {"#tail": "\n              ", "subclause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "by a pharmacy, is\n\t\t\t\tthe negotiated price at such pharmacy; or"}, "enum": {"#tail": "\n                  ", "#text": "(I)"}, "@id": "H510A1E3C04254F5497C6E688A84B40FE", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "other than by a pharmacy, is the average\n\t\t\t\tnegotiated price for the drug in the prescription drug plan in the zip code of\n\t\t\t\tthe enrollee as of the date the drug is dispensed.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(II)"}, "@id": "HCC910514C08C45D396FA45F162EB61C3", "#text": "\n                  "}], "enum": {"#tail": "\n                ", "#text": "(ii)"}, "header": {"#tail": "\n                ", "#text": "Negotiated\n\t\t\t\tprice"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "The negotiated price described in this clause, for a\n\t\t\t\tcovered part D drug which is dispensed to an enrollee\u2014"}, "#text": "\n                ", "@id": "H3927657E982345C99284A0F8698CAD48"}, {"#tail": "\n            ", "subclause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t\tthat is exempt from tax under ", "@entity-type": "act", "#text": "\n                      ", "external-xref": {"#tail": " of the Internal Revenue Code of 1986", "@parsable-cite": "usc/26/501", "#text": "section 501(c)(3)", "@legal-doc": "usc"}, "@value": "Internal Revenue Code of 1986/s:501/ss:c/p:3"}, {"#tail": ";", "@entity-type": "act", "#text": "section 501(a) of such Code", "@value": "Internal Revenue Code of 1986/s:501/ss:a"}], "#text": "is administered by\n\t\t\t\tan entity described in "}, "enum": {"#tail": "\n                  ", "#text": "(I)"}, "@id": "H36C0F255CE394BE4B5C839F936F124B8", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "takes title to the drugs and distributes\n\t\t\t\tthe drugs to eligible part D individuals free or at nominal charge on the basis\n\t\t\t\tof the entity\u2019s assessment of financial need of such individuals;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(II)"}, "@id": "H951D15C7AD584B56B747C8771AA8EC90", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ") is less\n\t\t\t\tthan the maximum income level for the taxpayer in the household to be eligible\n\t\t\t\tfor a refundable credit under such section; and", "@entity-type": "act", "#text": "\n                      ", "external-xref": {"#tail": " of the Internal Revenue Code of 1986", "@parsable-cite": "usc/26/36B", "#text": "section 36B", "@legal-doc": "usc"}, "@value": "Internal Revenue Code of 1986/s:36B"}, "#text": "does not\n\t\t\t\tdistribute the drugs to an individual unless the individual\u2019s household income\n\t\t\t\t(as determined under "}, "enum": {"#tail": "\n                  ", "#text": "(III)"}, "@id": "H5FFEE87C08494F8C9FDCF7A271EE8D59", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " establishes,\n\t\t\t\tconsistent with guidance and advisory opinions issued under ", "@entity-type": "federal-body", "#text": "Inspector General of the Department of Health and Human Services", "@entity-id": "7504"}, {"#tail": ", to\n\t\t\t\tprevent fraud or abuse in the application of this\n\t\t\t\tsubparagraph.", "@entity-type": "act", "#text": "section 1128D", "@value": "Internal Revenue Code of 1986/s:1128D"}], "#text": "meets such additional requirements as the\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(IV)"}, "@id": "HA4961FB079DF48968388B88367297239", "#text": "\n                  "}], "enum": {"#tail": "\n                ", "#text": "(iii)"}, "header": {"#tail": "\n                ", "#text": "Compassionate\n\t\t\t\ttreatment program defined"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " means, with respect to covered\n\t\t\t\tpart D drugs, a program that\u2014", "#text": "compassionate treatment program"}, "#text": "In this subparagraph, the term\n\t\t\t\t"}, "#text": "\n                ", "@id": "H7204D1A3FCD2487EAC5EB02D40014A5F"}], "enum": {"#tail": "\n              ", "#text": "(F)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Inclusion of\n\t\t\t\tnegotiated price of drugs provided under compassionate treatment\n\t\t\t\tprograms"}, "#text": "\n              ", "@id": "H0033FE0581294B1EA6EC53D95763303B"}}, "#text": "\n          ", "@id": "H8D3CCC99283B4B4CBE807056760DE86E"}], "#text": "\n        ", "@id": "H7B8F97E140294B6EA9B2F8ED53C11475"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall apply to drugs\n\t\t\t furnished in plan years beginning on or after January 1, 2014.", "@entity-type": "act", "#text": "subsection (a)", "@value": "Accessing Medicare Therapies Act of 2013/s:2/ss:a", "@proposed": "true"}, "#text": "The amendments made by "}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Effective\n\t\t\t date"}, "#text": "\n        ", "@id": "HC1BFC233868644E3AAC16774C88E3CEA"}], "#text": "\n      ", "@id": "H2FDD66953C924C298E779F2E04F7AE29"}], "#text": "\n\t\t", "@id": "H3C753FA01F96417BB265AB6AD16D0305"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2013-03-18"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 1239 IH: Accessing Medicare Therapies Act of 2013"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}